Prevision Policy provides health care policy analysis for business executives and investors. The firm brings unique experience to tracking, assessing and explaining regulatory and reimbursement policy that affect the biopharmaceutical industry. The company’s goal is to advance mutual understanding among policymakers, business executives and the investment community, in the belief that a deeper understanding of policy leads to better business, and a deeper understanding of business leads to better policy.
Prevision Policy’s founding members include Cole Werble, Michael McCaughan and Ramsey Baghdadi, the editorial team behind the RPM Report, an Elsevier Business Intelligence publication providing in-depth analysis of regulatory and reimbursement policy and their implications for market access in the pharmaceutical sector (www.TheRPMReport.com).
Cole Werble is the former owner and editorial director of FDC Reports, Inc., the publisher of The Pink Sheet, The Gray Sheet, and other leading news publications for the health care industry. He has more than 35 years of experience analyzing business critical developments affecting the biopharma sector and developing world class information products for the sector. He was most recently Senior Editorial Director for Elsevier Business Intelligence’s biopharma group.
Michael McCaughan acted most recently as editor-in-chief of EBI’s biopharma editorial group. McCaughan has 20 years of experience providing analysis and insight for EBI’s products, including The Pink Sheet, The Pink Sheet DAILY and The RPM Report. He speaks frequently on regulatory and policy developments affecting the industry.
Ramsey Baghdadi covered regulation, reimbursement, and legislative policy for over a decade, most recently as Editor-in-Chief of The RPM Report and a contributing editor to The Pink Sheet. He previously served as managing editor for the OTC drug and dietary supplement industry publication, The Tan Sheet.Prior to his work in the drug sector, he covered the medical device industry as financial editor of The Gray Sheet.
Laura Helbling is a reporter and analyst at Prevision Policy and The RPM Report. She has a degree in magazine journalism from the University of Missouri. Laura has focused on DTC advertising, Medicare Part D, REMS and other key regulatory issues at FDA.
Kate Rawson is a Contributing Editor at Prevision Policy. She was a Senior Editor at The RPM Report and reporter and editor at The Pink Sheet where she covered drug regulation and reimbursement issues. During her ten-year tenure at FDC Reports, she helped launch The Pink Sheet DAILY, and also served as Managing Editor of The Rose Sheet, which covers regulatory and business news of the cosmetics industry.
Jacqueline Fitton is a reporter/analyst at Prevision Policy and The RPM Report. She has a Bachelor’s degree in Biology and a Master’s degree in Science & Technology Policy (focusing on health policy) from Arizona State University.